Owens & Minor (NYSE:OMI) Releases FY 2025 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share guidance of 1.600-1.850 for the period, compared to the consensus earnings per share estimate of 1.790. The company issued revenue guidance of $10.9 billion-$11.2 billion, compared to the consensus revenue estimate of $11.0 billion. Owens & Minor also updated its FY25 guidance to $1.60-1.85 EPS.

Owens & Minor Stock Up 0.6 %

NYSE:OMI opened at $6.88 on Friday. Owens & Minor has a 1 year low of $6.07 and a 1 year high of $28.35. The stock has a 50-day moving average price of $11.57 and a two-hundred day moving average price of $13.30. The stock has a market cap of $530.82 million, a price-to-earnings ratio of -10.59, a PEG ratio of 0.20 and a beta of 0.48. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI) last announced its earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.53 by $0.02. The firm had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the company posted $0.69 EPS. As a group, equities analysts expect that Owens & Minor will post 1.51 earnings per share for the current year.

Analyst Ratings Changes

OMI has been the subject of a number of research analyst reports. UBS Group reduced their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Citigroup reduced their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Robert W. Baird dropped their target price on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Barclays reduced their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $14.92.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.